Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Glaukos Corp
6GJCurrent price
112 EUR
0 EUR (0.00%)
Last closed
126.28 USD
Company
www.glaukos.com
ISIN
US3773221029
Sector
Healthcare
Industry
Medical Devices
Exchange
Frankfurt Exchange
Capitalization
6 939 149 312 USD
Yield for 12 month
+64.53 %
1Y
3Y
5Y
10Y
15Y
6GJ
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California. Address: One Glaukos Way, Aliso Viejo, CA, United States, 92656
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
136.91 USDP/E ratio
–Dividend Yield
–Current Year
+314 711 000 USD
Last Year
+282 862 000 USD
Current Quarter
+95 690 000 USD
Last Quarter
+85 622 000 USD
Current Year
+239 136 000 USD
Last Year
+213 883 000 USD
Current Quarter
+73 140 000 USD
Last Quarter
+65 364 000 USD
Key Figures 6GJ
1 year
3 years
5 years
10 years
EBITDA
-84 563 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-7.96 %
PEG Ratio
1.64
Return On Equity TTM
-27.49 %
Wall Street Target Price
136.91 USD
Revenue TTM
341 724 992 USD
Book Value
12.13 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
19 %
Dividend Yield
–
Gross Profit TTM
213 883 000 USD
Earnings per share
-3.19 USD
Diluted Eps TTM
-3.19 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
1896.3 %
Profit Margin
-46.41 %
Dividend Analytics 6GJ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 6GJ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 6GJ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
19.9988
Price Sales TTM
20.3062
Enterprise Value EBITDA
-57.892
Price Book MRQ
10.4323
Financials 6GJ
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 6GJ
For 52 weeks
59.22 USD
136.61 USD
50 Day MA
124.29 USD
Shares Short Prior Month
2 593 417
200 Day MA
101.74 USD
Short Ratio
4.74
Shares Short
2 565 567
Short Percent
7.5 %
BeatStart